Suppr超能文献

不同类型淋巴细胞的溶酶体酶转移

Lysosomal enzyme transfer from different types of lymphoid cell.

作者信息

Olsen I, Bou-Gharios G, Abraham D, Chain B

机构信息

Kennedy Institute of Rheumatology, Hammersmith, London, United Kingdom.

出版信息

Exp Cell Res. 1993 Nov;209(1):133-9. doi: 10.1006/excr.1993.1293.

Abstract

The direct transfer of certain lysosomal enzymes during cell-to-cell contact between normal lymphocytes and enzyme-deficient recipient cells has previously been reported in vitro and may play an important role in the correction of lysosomal storage diseases by bone marrow transplantation in vivo. In the present study we have used a number of different T, B, and plasma cell lines to examine the expression and immunological specificity of the transfer of the lysosomal enzyme, beta-glucuronidase (Gus). Each of these groups of cell had differing intracellular and secreted levels of Gus activity, which were nevertheless similar within each group. Dermal fibroblasts deficient in the Gus enzyme acquired substantial amounts of additional activity when they were cultured together with the T cells, the B cells, or the plasma cells. This occurred by the direct transfer of Gus from all three types of cell. In addition, with plasma cells, which had very high intracellular enzyme activity and also secreted high levels of Gus into their culture medium, the secreted enzyme was readily internalized by the fibroblasts via the mannose 6-phosphate receptor (MPR). It was notable that the purified endogenous enzymes from plasma cells as well as from B cells, but not from T cells, were also endocytosed by the fibroblasts utilizing this receptor-mediated process. Although the Gus activity from all the cell lines examined had the same molecular size, polyacrylamide electrophoresis and isoelectric focusing patterns showed that the immunologically distinct types of lymphoid cell have characteristic, unique pathways of post-translational lysosomal enzyme processing. These results show that the transfer of lysosomal enzymes from lymphoid cells can occur by two distinct mechanisms, both likely to have important roles in enzyme replacement therapy.

摘要

此前已有体外研究报道,在正常淋巴细胞与酶缺陷受体细胞进行细胞间接触时,某些溶酶体酶可直接转移,这可能在体内骨髓移植纠正溶酶体贮积病中发挥重要作用。在本研究中,我们使用了多种不同的T细胞、B细胞和浆细胞系,以检测溶酶体酶β-葡萄糖醛酸酶(Gus)转移的表达情况及免疫特异性。每组细胞的细胞内和分泌型Gus活性水平各不相同,但每组内的活性水平相似。缺乏Gus酶的皮肤成纤维细胞在与T细胞、B细胞或浆细胞共同培养时,可获得大量额外活性。这是通过Gus从这三种类型细胞的直接转移实现的。此外,浆细胞的细胞内酶活性非常高,且向培养基中分泌高水平的Gus,分泌的酶可通过甘露糖6-磷酸受体(MPR)被成纤维细胞轻易内化。值得注意的是,利用这种受体介导的过程,来自浆细胞以及B细胞(而非T细胞)的纯化内源性酶也可被成纤维细胞内吞。尽管所检测的所有细胞系的Gus活性具有相同的分子大小,但聚丙烯酰胺凝胶电泳和等电聚焦图谱显示,免疫特性不同的淋巴细胞具有特征性的、独特的溶酶体酶翻译后加工途径。这些结果表明,溶酶体酶从淋巴细胞的转移可通过两种不同机制发生,这两种机制可能在酶替代疗法中均发挥重要作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验